A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis

Clinical trial NCT03653026 · COMPLETED

Trial details

NCT number: NCT03653026
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ulcerative Colitis (UC)

Start date: 2018-12-06
Primary completion: 2021-01-14
Enrollment: 522

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.